Deferred Tax Assets, Valuation Allowance of Hoth Therapeutics, Inc. from 31 Dec 2017 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Hoth Therapeutics, Inc. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2017 to 31 Dec 2024.
  • Hoth Therapeutics, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2024 was $17,671,982, a 16% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

Hoth Therapeutics, Inc. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $17,671,982 +$2,478,270 +16% 31 Dec 2024 10-K 28 Mar 2025 2024 FY
Q4 2023 $15,193,712 +$2,380,338 +19% 31 Dec 2023 10-K 28 Mar 2025 2024 FY
Q4 2022 $12,813,374 +$4,528,681 +55% 31 Dec 2022 10-K 28 Mar 2024 2023 FY
Q4 2021 $8,284,693 +$4,259,488 +106% 31 Dec 2021 10-K 31 Mar 2023 2022 FY
Q4 2020 $4,025,205 +$1,489,096 +59% 31 Dec 2020 10-K 30 Mar 2022 2021 FY
Q4 2019 $2,536,109 +$1,692,939 +201% 31 Dec 2019 10-K 16 Mar 2021 2020 FY
Q4 2018 $843,170 +$417,778 +98% 31 Dec 2018 10-K 02 Mar 2020 2019 FY
Q4 2017 $425,392 31 Dec 2017 10-K 01 Apr 2019 2018 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.